Orexins promote survival of rat cortical neurons

Neuroscience Letters

Volumn 506, Issue 2, 2012, Pages 303-306

  Sokołowska, Paulina ^a   Urbańska, Anna ^a   Namiecińska, Magdalena ^a   Biegańska, Kaja ^a,b   Zawilska, Jolanta B ^a,b  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Caspase 3; Cell viability; Hypocretin; Neurons; Neuroprotection; Orexin

Indexed keywords

ALANINE DEXTRO LEUCINE OREXIN B; CASPASE 3; NEUROPEPTIDE; OREXIN; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENUATION; BRAIN CELL; BRAIN CORTEX; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MEDIATOR; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR POTENTIAL;

ANIMALS; CASPASE 3; CELL SURVIVAL; CEREBRAL CORTEX; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; NEUROPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 84655167918     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.11.028     Document Type: Article

References (33)

1. 2 receptors by orexin peptides. J. Pharmacol. Exp. Ther. 2003, 305:507-514.
2. 1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase. J. Biol. Chem. 2006, 281:834-842.
3. Anderson C.M., Nedergaard M. Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci. 2003, 26:340-344.
4. 15]orexin-B. Bioorg. Med. Chem. Lett. 2003, 13:111-113.
5. Biegańska K., Sokołowska P., Namiecińska M., Urbańska A., Sobczak E., Zawilska J.B. Effects of orexins on survival of rat C6 glioma cells. A comparison to the primary rat astrocyte cell cultures. Acta Neurobiol. Exp. 2011, 71:66.
6. Biegańska K., Urbańska A., Woldan-Tambor A., Zawilska J.B. Hipocretins (orexins) and their receptors: structure, localization and molecular mechanisms of action. Post. Biol. Kom. 2011, 38:333-348.
7. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 1995, 42:483-674.
8. de Lecea L., Kilduff T.S., Peyron C., Gao X.-B., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L.F., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:322-327.
9. Digby J.E., Chen J., Tang J.Y., Lehnert H., Matthews R.N., Randeva H.S. Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J. Endocrinol. 2006, 191:129-136.
10. 2+ influx and ERK. Biochem. Biophys. Res. Commun. 2007, 353:475-480.
11. 1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms. J. Biol. Chem. 2005, 280:6570-6579.
12. 1 orexin/hypocretin receptors. Cell. Mol. Life Sci. 2008, 65:1948-1956.
13. Karteris E., Chen J., Randeva H.S. Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system. J. Clin. Endocrinol. Metab. 2004, 89:1957-1962.
14. Kukkonen J.P., Holmqvist T., Ammoun S., åkerman K.E.O. Functions of the orexinergic/hypocretinergic system. Am. J. Physiol. Cell Physiol. 2002, 283:1567-1591.
15. Kuwaki T. Hypothalamic modulation of breathing. Adv. Exp. Med. Biol. 2010, 669:243-247.
16. Masmoudi-Kouki O., Gandolfo P., Castel H., Leprince J., Fournier A., Dejda A., Vaudry H., Tonon M.C. Role of PACAP and VIP in astroglial function. Peptides 2007, 28:1753-1760.
17. Ramanjaneya M., Conner A.C., Chen J., Kumar P., Brown J.E.P., Jöhren O., Lehnert H., Stanfield P.R., Randeva H.S. Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signaling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B. J. Endocrinol. 2009, 202:249-261.
18. Ransom B., Behar T., Nedergaard M. New roles for astrocytes (stars at last). Trends Neurosci. 2003, 26:520-522.
19. 1 receptor suppress cell growth by inducing apoptosis. J. Biol. Chem. 2004, 279:45875-45886.
20. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
21. Sakurai T. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regul. Pept. 2005, 126:3-10.
22. Sikder D., Kodadek T. The neurohormone orexin stimulates hypoxia-inducible factor-1 activity. Genes Dev. 2007, 21:2995-3005.
23. Silveyra P., Lux-Lantos V., Libertun C. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E977-E985.
24. Spinazzi R., Andreis P.G., Rossi G.P., Nussdorfer G.G. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol. Rev. 2006, 58:46-57.
25. Tang J., Chen J., Ramanjaneya M., Punn A., Conner A.C., Randeva H.S. The signaling profile of recombinant human orexin-2 receptor. Cell. Signal. 2008, 20:1651-1661.
26. Thompson J.L., Borgland S.L. A role for hypocretin/orexin in motivation. Behav. Brain Res. 2011, 217:446-453.
27. 1 orexin receptors. Br. J. Pharmacol. 2010, 159:212-221.
28. 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. J. Mol. Neurosci. 2011, 10.1007/s12031-011-9526-2.
29. Voisin T., Rouet-Benzineb P., Reuter N., Laburthe M. Orexins and their receptors: structural aspects and role in peripheral tissues. Cell. Mol. Life Sci. 2003, 60:72-87.
30. Voisin T., El Firar A., Avondo V., Laburthe M. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology 2006, 147:4977-4984.
31. 1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis. Cancer Res. 2011, 71:3341-3351.
32. Wieland H.A., Soll R.M., Doods H.N., Stenkamp D., Hurnaus R., Lammle B., Beck-Sickinger A.G. The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor. Eur. J. Biochem. 2002, 269:1128-1135.
33. Zhang W., Zhang N., Sakurai T., Kuwaki T. Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdale and bed nucleus of the stria terminalis. Brain Res. 2009, 1262:25-37.